Lam Research (LRCX) Tops Q3 EPS by 50c, Beats on Revenue; Offers Q4 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts LRCX Hot Sheet
Price: $221.43 -4.03%
Financial Fact:
Diluted net income (loss) per share: 1.47
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Diluted net income (loss) per share: 1.47
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Lam Research (NASDAQ: LRCX) reported Q3 EPS of $7.79, $0.50 better than the analyst estimate of $7.29. Revenue for the quarter came in at $3.79 billion versus the consensus estimate of $3.72 billion.
GUIDANCE:
Lam Research sees Q4 2024 revenue of $3.5-4.1 billion, versus the consensus of $3.77 billion.
For earnings history and earnings-related data on Lam Research (LRCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
